Announcements Trials
Browse Landscape

Phase

Phase 2 4

Status

Recruiting 3Unknown 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 10Thoracic 9Sarcoma 4Head & Neck 3Gynecologic 1Genitourinary 1Gastrointestinal 1

Conditions

Osteosarcoma 2Triple Negative Breast Neoplasms 1Sarcoma, Ewing 1Pathologic Complete Response 1Neoplasms 1Hemangiosarcoma 1Breast Neoplasms 1

Interventions

Cyclophosphamide 93Doxorubicin 92Radiotherapy 87Temozolomide 69Filgrastim 58Ifosfamide 55Bevacizumab 55Etoposide 48Gemcitabine 44Imatinib Mesylate 43Vincristine 40pembrolizumab 35pazopanib 34Peripheral Blood Stem Cell Transplantation 31Methotrexate 31Nivolumab 30Carboplatin 30fludarabine phosphate 29Irinotecan 29Cisplatin 28Paclitaxel 26Melphalan 26Magnetic Resonance Spectroscopy 26Docetaxel 25Busulfan 25Trabectedin 24apatinib 22Specimen Handling 21Sirolimus 21Antilymphocyte Serum 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × trilaciclib × Sarcoma × Clear all
NCT01042379 2026-05-06

I-SPY

QuantumLeap Healthcare Collaborative

Phase 2 Recruiting
5,000 enrolled
BreastSarcoma

Pathologic Complete Response, Breast Neoplasms, Hemangiosarcoma, Neoplasms, Triple Negative Breast Neoplasms

NCT06714383 2024-12-03

Trilaciclib Combing Chemotherapy in the Neoadjuvant Treatment of Osteosarcoma

Peking University People's Hospital

Phase 2 Recruiting
50 enrolled
Sarcoma

Osteosarcoma

NCT06699472 2024-11-21

A Prospective, Randomized, Controlled Clinical Study on the Prevention of Chemotherapy Related Myelosuppression in Patients with Ewing's Sarcoma Using Trilaciclib

Fudan University

Phase 2 Recruiting
22 enrolled
Sarcoma

Sarcoma, Ewing

NCT06217003 2024-01-22

Trilaciclib Combined With Chemotherapy for Perioperative Treatment of Osteosarcoma

The First Affiliated Hospital of Xinxiang Medical College

Phase 2 Unknown
20 enrolled
Sarcoma

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡